The alterations in the concentration and composition of lipoproteins that occur in liver disease indicate the central role of the liver in lipoprotein metabolism. A number of studies have characterized plasma lipoproteins in patients with liver disease, although in most cases the underlying molecular defects responsible for the changes are still undetermined.